Humacyte, Inc. — Director's Dealing 2022

Sep 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2022-09-15

Reporting Person: Niklason Laura E (Director, President, CEO and Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-15	Common Stock	P	2000	$4.14	Acquired	1160240	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	510161	Indirect
Common Stock	18930004	Indirect